Paris-based Aqemia picks up €30 million capital injection to uncover breakthrough drug discoveries at scale

Published on October 19, 2022

Pharmatech startup Aqemia has just raised €30 million in a new funding round. The Parisian startup is generating a pioneering drug discovery pipeline that aims to design fast drugs for critical diseases through an AI-powered process that allows drug discovery projects to be scaled like tech projects. One of the core challenges in western medicine…

This content is for members only. Visit the site and log in/register to read.

The post Paris-based Aqemia picks up €30 million capital injection to uncover breakthrough drug discoveries at scale appeared first on EU-Startups.